Matches in Nanopublications for { ?s ?p "[Loss of PTEN was recently shown to contribute to resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) in EGFR mutation-positive non-small cell lung cancer (NSCLC) through activation of the protein kinase AKT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP189640.RAMUN4dcZjUdUSzqWTG5B43g6hVPReeU_i_Eox4QtpR0k130_assertion description "[Loss of PTEN was recently shown to contribute to resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) in EGFR mutation-positive non-small cell lung cancer (NSCLC) through activation of the protein kinase AKT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP189640.RAMUN4dcZjUdUSzqWTG5B43g6hVPReeU_i_Eox4QtpR0k130_provenance.
- NP937984.RAVlxbyt9V6R42CNzVj2rsEBn9Y-LGmjSKxRX_YeIHWwk130_assertion description "[Loss of PTEN was recently shown to contribute to resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) in EGFR mutation-positive non-small cell lung cancer (NSCLC) through activation of the protein kinase AKT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP937984.RAVlxbyt9V6R42CNzVj2rsEBn9Y-LGmjSKxRX_YeIHWwk130_provenance.